Emergency & Acute Psychiatry at AAAP 37th Annual Meeting and Scientific Symposium

11 sessions on emergency & acute psychiatry · November 12–15, 2026, Memphis, TN. Compare emergency & acute psychiatry at other meetings →

Friday, November 13

  • 15:30–17:00 · Oral abstract

    Medications for Opioid Use Disorder in VHA Acute Care Settings: A Quality Improvement Study

    Brian Fuehrlein

    Quality improvement study of MOUD delivery in VHA acute care settings.

    Opioid Use Disorder

  • 15:30–17:00 · Oral abstract

    Substance Use and Outcomes following Intramuscular Antipsychotic Treatment for Acute Pediatric Agitation: A Retrospective Cohort Study

    Angelo Chaia

    Retrospective study of outcomes after intramuscular antipsychotics for pediatric agitation, by substance use status.

    Antipsychotic Prescribing · Child & Adolescent · Substance Use Disorders

Sunday, November 15

Posters (7)

  • Impact of Cannabis Legalization on Emergency Department Visits, Cannabis-Induced Psychosis, and Psychiatric Outcomes: A Community Hospital Analysis — Jaskaran Singh
  • Importance of Aggressive Early Treatment of Medetomidine Withdrawal — Kiana Malta
  • Improving Identification and Treatment of Substance Use Disorders in Inpatient Psychiatry — Sean Woytowitz
  • Intravenous Use of Bupropion as a Cocaine Substitute: Examining its Acute Clinical Effects in a Psychiatric Crisis Center — Dennis Grapsas
  • Predictors of Buprenorphine Retention following Emergency Department-Initiated Opioid Use Disorder Program — Haley Kvarnberg
  • Laissez Les MOUD Rouler: Laying the Foundation for Emergency Department Buprenorphine Expansion in Louisiana Using the Bridge Starts Curriculum — Jordan Brandt
  • Predictors of Prolonged Boarding and Short-Term Psychiatric Emergency Service Revisits Among Veterans — Khaled Draghmeh

Schedule to be announced

Other topics at this meeting

Substance Use Disorders 87Opioid Use Disorder 48Cannabis & Cannabinoids 17Alcohol Use Disorder 16Child & Adolescent 14Drug Interactions & Safety 13Education & Training 12Schizophrenia & Psychosis 12Digital Psychiatry & AI 8Practice, Policy & Workforce 8PTSD & Trauma 8Long-Acting Injectables 7

Full program overview →